Literature DB >> 11571256

AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

S C Smith, S N Blair, R O Bonow, L M Brass, M D Cerqueira, K Dracup, V Fuster, A Gotto, S M Grundy, N H Miller, A Jacobs, D Jones, R M Krauss, L Mosca, I Ockene, R C Pasternak, T Pearson, M A Pfeffer, R D Starke, K A Taubert.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11571256     DOI： 10.1161/hc3801.097475

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  84 in total

1.  [From cardiac rehabilitation to prevention].

Authors:  Hugo Saner
Journal:  Wien Klin Wochenschr       Date:  2003-11-28       Impact factor: 1.704

Review 2.  In-hospital initiation of statin therapy in patients with acute coronary events.

Authors:  Gregg C Fonarow
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

3.  [Cardiovascular prevention and rehabilitation].

Authors:  C von Schacky
Journal:  Internist (Berl)       Date:  2003-12-20       Impact factor: 0.743

4.  [Statin therapy in patients with acute coronary syndrome. "Prove-it" study].

Authors:  C von Schacky
Journal:  Internist (Berl)       Date:  2004-12       Impact factor: 0.743

5.  Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women.

Authors:  Jeffrey S Berger; Aileen P McGinn; Barbara V Howard; Lewis Kuller; Joann E Manson; Jim Otvos; J David Curb; Charles B Eaton; Robert C Kaplan; John K Lynch; Daniel M Rosenbaum; Sylvia Wassertheil-Smoller
Journal:  Stroke       Date:  2012-02-02       Impact factor: 7.914

6.  Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424.

Authors:  Leslee J Shaw; Gary V Heller; Paul Casperson; Romalisa Miranda-Peats; Piotr Slomka; John Friedman; Sean W Hayes; Ronald Schwartz; William S Weintraub; David J Maron; Marcin Dada; Spencer King; Koon Teo; Pamela Hartigan; William E Boden; Robert A O'Rourke; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

7.  ACE inhibitors in patients with vascular disease: should the PEACE trial change medical practice?

Authors:  Robert M Carey
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

8.  Using "get with the guidelines" to prevent recurrent cardiovascular disease.

Authors:  Kenneth A LaBresh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-08

Review 9.  Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians.

Authors:  Stacey Sheridan; Michael Pignone; Cynthia Mulrow
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

10.  Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial.

Authors:  Steven M Edworthy; Bonnie Baptie; Donna Galvin; Rollin F Brant; Terry Churchill-Smith; Dante Manyari; Israel Belenkie
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.